Drug Products: Biologics, Biosimilars and Interchangeables
Issues And Trends In Healthcare Delivery System
Microorganisms in Medicine and Therapeutics
The Central Dogma
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 10, 2025

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
Published on: May 18, 2020
Thomas Scheper1, Sascha Beutel2, Nina McGuinness2
1Institute of Technical Chemistry, Leibniz University Hannover, Hannover, Germany. Scheper@iftc.uni-hannover.de.
Digitalization, machine learning (ML), and artificial intelligence (AI) can accelerate biopharmaceutical production. Integrating these technologies and addressing regulatory issues early can overcome bottlenecks in industrial bioprocessing.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: